LifeStance Health Group, Inc.LFSTNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank83
5Y CAGR+18.9%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

5Y CAGR
+18.9%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM5.53%+73.5%
20243.19%+132.1%
2023-9.94%+40.5%
2022-16.71%+53.5%
2021-35.96%-1647.6%
20202.32%-76.9%
201910.04%-